CD44 and ovarian carcinoma: While CD44 expression was associated with unfavorable prognostic outcome in FIGO III and IV ovarian cancer in one study [66], Zhang and colleagues reported no correlation between CD44 expression and prognosis in advanced stage ovarian cancer [67].